Background: Copy number variation sequencing (CNV-seq) is a powerful tool to discover structural genomic variation, but limitations associated with its retrospective study design and inadequate diversity of participants can be impractical for clinical application. Aim: This study aims to use CNV-seq to assess chromosomal aberrations in pregnant Vietnamese women. Materials & methods: A large-scale study was conducted on 3776 pregnant Vietnamese women with abnormal ultrasound findings. Results: Chromosomal aberrations were found in 448 (11.86%) women. Of these, 274 (7.26%) had chromosomal aneuploidies and 174 (4.61%) carried pathogenic/likely pathogenic CNVs. Correlations were established between chromosomal aberrations and various phenotypic markers. Conclusion: This comprehensive clinical study illuminates the pivotal role of CNV-seq in prenatal diagnosis for pregnancies featuring fetal ultrasound anomalies.

Keywords:

References

1. Whitworth M, Bricker L, Mullan C. Ultrasound for fetal assessment in early pregnancy. Cochrane Datab. Syst. Rev. 2015(7), Cd007058 (2015).
MedlineGoogle Scholar
2. Doubilet PM. Ultrasound evaluation of the first trimester. Radiol. Clin. North Am. 52(6), 1191–1199 (2014).
MedlineGoogle Scholar
3. Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Datab. Syst. Rev. 9(9), Cd003252 (2017).
MedlineGoogle Scholar
4. Shaffer LG, Dabell MP, Fisher AJ et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat. Diagn. 32(10), 976–985 (2012).
MedlineGoogle Scholar
5. Lo JO, Shaffer BL, Feist CD, Caughey AB. Chromosomal microarray analysis and prenatal diagnosis. Obstet. Gynecol. Surv. 69(10), 9 (2014).
Google Scholar
6. Dugoff L, Norton ME, Kuller JA. The use of chromosomal microarray for prenatal diagnosis. Am. J. Obstet. Gynecol. 215(4), B2–B9 (2016).
Medline CASGoogle Scholar
7. Martin CL, Kirkpatrick BE, Ledbetter DH. Copy number variants, aneuploidies, and human disease. Clin. Perinatol. 42(2), 227–242; vii (2015).
MedlineGoogle Scholar
8. Zhao M, Wang Q, Wang Q, Peilin J, Zhao Z. Computational tools for CNV detection using NGS features and perspectives. Presented at: The Second Workshop on Data Mining of Next-Generation Sequencin in Conjunction with the 2012 IEEE International Conference on Bioinformatics and Biomedicine. Philadelphia, PA (2012).
Google Scholar
9. Wang J, Chen L, Zhou C et al. Identification of copy number variations among fetuses with ultrasound soft markers using next-generation sequencing. Sci. Rep. 8(1), 8134 (2018).
MedlineGoogle Scholar
10. Cai M, Lin N, Chen X et al. Evaluation of chromosomal abnormalities and copy number variations in fetuses with ultrasonic soft markers. BMC Med. Genom. 14(1), 19 (2021).
Medline CASGoogle Scholar
11. Hu T, Tian T, Zhang Z et al. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am. J. Obstet. Gynecol. 224(5), 516.e511–516.e516 (2021).
Google Scholar
12. Hu P, Wang Y, Sun R et al. Copy number variations with isolated fetal ventriculomegaly. Curr. Mol. Med. 17(2), 133–139 (2017).
Medline CASGoogle Scholar
13. Cai M, Huang H, Su L et al. Choroid plexus cysts: single nucleotide polymorphism array analysis of associated genetic anomalies and resulting obstetrical outcomes. Risk Manag. Healthc Policy 14, 2491–2497 (2021).
MedlineGoogle Scholar
14. Singer A, Maya I, Koifman A et al. Microarray analysis in pregnancies with isolated echogenic bowel. Early Hum. Dev. 119, 25–28 (2018).
Medline CASGoogle Scholar
15. Gu YZ, Nisbet DL, Reidy KL, Palma-Dias R. Hypoplastic nasal bone: a potential marker for facial dysmorphism associated with pathogenic copy number variants on microarray. Prenat. Diagn 39(2), 116–123 (2019).
Medline CASGoogle Scholar
16. He M, Zhang Z, Hu T, Liu S. Chromosomal microarray analysis for the detection of chromosome abnormalities in fetuses with echogenic intracardiac focus in women without high-risk factors. Medicine (Baltimore) 99(5), e19014 (2020).
Medline CASGoogle Scholar
17. Su J, Qin Z, Fu H et al. Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort. Ultrasound Obstet. Gynecol. 59(2), 226–233(2021).
Google Scholar
18. An G, Lin Y, Xu LP et al. Application of chromosomal microarray to investigate genetic causes of isolated fetal growth restriction. Mol. Cytogenet. 11, 33 (2018).
MedlineGoogle Scholar
19. Angras K, Bailey AL, Singh KP, Young JA, Ross J. A retrospective review of copy number variants and ultrasound-detected soft markers. Mol.Genet. Med. 14(2), 1–4 (2020).
Google Scholar
20. Lord J, Mcmullan DJ, Eberhardt RY et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 393(10173), 747–757 (2019).
Medline CASGoogle Scholar
21. Wang J, Chen L, Zhou C et al. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing. Am. J. Obstet. Gynecol. 219(3), 287.e281–287.e218 (2018).
Google Scholar
22. Scheinin I, Sie D, Bengtsson H et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 24(12), 2022–2032 (2014).
Medline CASGoogle Scholar
23. Riggs ER, Andersen EF, Cherry AM et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 22(2), 245–257 (2020).
MedlineGoogle Scholar
24. Whitford W, Lehnert K, Snell RG, Jacobsen JC. Evaluation of the performance of copy number variant prediction tools for the detection of deletions from whole genome sequencing data. J. Biomed. Inform 94, 103174 (2019).
MedlineGoogle Scholar
25. Jang W, Kim Y, Han E et al. Chromosomal microarray analysis as a first-tier clinical diagnostic test in patients with developmental delay/intellectual disability, autism spectrum disorders, and multiple congenital anomalies: a prospective multicenter study in Korea. Ann. Lab. Med. 39(3), 299–310 (2019).
Medline CASGoogle Scholar
26. Sun Y, Zhang P, Zhang N et al. Cytogenetic analysis of 3387 umbilical cord blood in pregnant women at high risk for chromosomal abnormalities. Mol. Cytogenet 13, 2 (2020).
Medline CASGoogle Scholar
27. Brison N, Neofytou M, Dehaspe L et al. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing. Prenat. Diagn. 38(4), 258–266 (2018).
Medline CASGoogle Scholar
28. Wapner RJ, Martin CL, Levy B et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N. Engl. J. Med. 367(23), 2175–2184 (2012).
Medline CASGoogle Scholar
29. Hu T, Tian T, Zhang Z et al. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am. J. Obstet. Gynecol. 224(5), 516.e511–516.e516 (2021).
Google Scholar
30. Leite A, Pinto IP, Leijsten N et al. Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil. PLOS ONE 17(4), e0266493 (2022).
Medline CASGoogle Scholar
31. Du Y, Ren Y, Yan Y, Cao L. Absent fetal nasal bone in the second trimester and risk of abnormal karyotype in a prescreened population of Chinese women. Acta Obstet. Gynecol. Scand 97(2), 180–186 (2018).
Medline CASGoogle Scholar
32. Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet. Gynecol. 41(3), 247–261 (2013).
Medline CASGoogle Scholar
33. Peng R, Zheng J, Xie HN, He M, Lin MF. Genetic anomalies in fetuses with tetralogy of Fallot by using high-definition chromosomal microarray analysis. Cardiovasc. Ultrasound 17(1), 8 (2019).
MedlineGoogle Scholar
34. Toxværd ME, Garne E. Epidemiology of multiple congenital anomalies before and after implementation of a nationwide prenatal screening program in Denmark. Front. Pediatr. 9, 614864 (2021).
MedlineGoogle Scholar

Ahead of Print

Metrics

Downloaded 23 times

History

Received 10 October 2023

Accepted 23 February 2024

Published online 4 April 2024

Information

Keywords

Author contributions

Study concept and design: H Giang, H-S Tang, PMD, H-N Nguyen; obtaining funding: NHN, HG; Data acquisition: D-C Tran, D-A Nguyen, QT Le, DT Thi Hoang, TNT, TM Thi Ha, TL Dinh, CC Nguyen, KP Thi Doan, LA Thi Luong, TS Vo, TH Nhat Trinh, VT Nguyen, TT Thi Do, Q-T Thi Nguyen, D-K Truong; laboratory work: H-T Thi Dao, P-A Ngoc Vo, Y-N Nguyen, M-A Dinh; Data analysis: H-T Thi Dao, H-D Luu Nguyen, MN Phan, P-L Doan, TH Nhat Trinh, H-S Tang, MDP, H Giang. Drafting the manuscript: PMD, D-C Tran and MN Phan; critical revision of the manuscript for intellectual content: PMD, H Giang. All authors contributed to and approved the final manuscript.

Acknowledgments

We thank all patients who participated in this study and gave consent to report findings in this paper. We thank A Jansen of Angela Jansen & Associates, for her editorial services in preparing the manuscript for publication.

Financial disclosure

Gene Solutions, Vietnam funded this study. The funder did not have any role in the study design, data collection, analysis, publishing decision, or manuscript preparation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Data availability statement

The data supporting this study's findings are available from the corresponding authors, (HST, HG), upon reasonable request.

Ethics statements

The ethics and scientific committee of the University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam, approved this study (Approval number: 164/HDDD). The study complied with the guidelines set by the University of Medicine and Pharmacy, Ho Chi Minh City, for managing the human genetic data of all participants. All written informed consent forms were collected from the study participants after a session of genetic counselling and with their agreement.

PDF download